Home › Funds › Commodore Capital LP › ATOS

Commodore Capital LP position in ATOS

ATOSSA THERAPEUTICS INC · Health Care

Commodore Capital LP reported holding 1,160,000 shares of ATOS (ATOSSA THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$19.9M, representing 1.54% of its reported portfolio and ranking #20 among its reported holdings. Commodore Capital LP first reported this position in Q3 2026.

Latest position (Q3 2026)1.16M sh
Reported value held$19.88M
Portfolio Weight1.54%
First reportedQ3 2026
Last changeNew
Updated2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

How Commodore Capital LP's ATOS position evolved

Commodore Capital LP first disclosed a stake in ATOS in Q3 2026 at 1,160,000 shares (US$19.9M).

Quarter by quarter

QuarterSharesValueChange
Q3 2026 1.16M $19.88M New

About ATOS and 13F data

ATOS (ATOSSA THERAPEUTICS INC) is a Health Care company. 62 other funds we track also report a position in ATOS — the largest reported positions include Frazier Life Sciences Management, L.P. (US$120.8M), venBio Partners LLC (US$71.7M), Deep Track Capital, LP (US$55.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ATOS

All ATOS fund holders →

FAQ

How long has Commodore Capital LP held ATOS?

Commodore Capital LP has disclosed ATOS holdings in 1 of the last 1 reported quarters, going back to Q3 2026.

What is Commodore Capital LP's current position in ATOS?

As of Q3 2026, Commodore Capital LP holds 1.16M shares of ATOS (ATOSSA THERAPEUTICS INC), valued at $19.88M, representing 1.54% of its reported portfolio and ranking #20.

Has Commodore Capital LP been buying or selling ATOS?

In the latest 13F filing (Q3 2026), Commodore Capital LP newly opened its position in ATOS.

Which other funds hold ATOS?

Other major institutional holders of ATOS include Frazier Life Sciences Management, L.P., venBio Partners LLC, Deep Track Capital, LP, among 62 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.